Europe Clinical Trials Support Services Market Forecast 2022-2030
KEY FINDINGS
The Europe clinical trials support services market is predicted to record a 7.96% CAGR over the estimation period, 2022 and 2030. Excellent patient recruitment rates and high-quality patient data accelerate market growth in the region.
MARKET INSIGHTS
The Europe clinical trials support services market growth assessment entails the evaluation of Germany, France, Denmark, Hungary, United Kingdom, Spain, Sweden, Italy, and Rest Of Europe. France’s research and development sector are highly competitive in terms of skill levels and structure. France’s regulatory approval process is quite slow, usually taking 236 days to complete. The main aim of the LEEM and the French government is to position France as the European leader in clinical research. Also, many key players in France offer clinical trial support services, driving their growth in France.
Recently, Italy has emerged as a key destination for global clinical trial programs, mostly focusing on medicines, knowledge, skills, and economic benefits. The Italian population has also started taking a keen interest in participating in clinical research. Additionally, there was an increase of 14% in global clinical trial participation compared to 2020.
On the other hand, in Sweden, clinical trials are important in developing new, appropriate medicinal products for humans and animals and medical devices and monitoring their use in healthcare. Pharmaceutical companies provide value to Swedish society through clinical trials. The positive economic effects of trials conducted in Sweden stem from various factors, including contributions to more and better healthcare, the creation of highly productive jobs, and drug cost savings.
COMPETITIVE INSIGHTS
Top players operating in the market entails KCR, ICON PLC, Alcura Health, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
- 1. Research Scope & Methodology
- 1.1. Study Objectives
- 1.2. Scope Of Study
- 1.3. Methodology
- 1.4. Assumptions & Limitations
- 2. Executive Summary
- 2.1. Market Size & Estimates
- 2.2. Market Overview
- 3. Market Dynamics
- 3.1. Key Drivers
- 3.1.1. Rising Prevalence Of Chronic Disease & Virus Outbreaks
- 3.1.2. Benefits Of Clinical Trial Support Services
- 3.2. Key Restraints
- 3.2.1. Availability Of Open-source/Freeware Software
- 3.2.2. Stringent Regulations
- 4. Key Analytics
- 4.1. Impact Of Covid-19 On Clinical Trials Support Services Market
- 4.2. Key Market Trends
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Buyers Power
- 4.3.2. Suppliers Power
- 4.3.3. Substitution
- 4.3.4. New Entrants
- 4.3.5. Industry Rivalry
- 4.4. Opportunity Matrix
- 4.5. Vendor Landscape
- 4.6. Value Chain Analysis
- 4.7. Key Buying Criteria
- 4.7.1. Performance
- 4.7.2. Ease Of Use
- 4.7.3. Security
- 4.7.4. Cost-effectiveness
- 4.8. Regulatory Framework
- 5. Market By Phase
- 5.1. Phase I
- 5.2. Phase Ii
- 5.3. Phase Iii
- 5.4. Phase Iv
- 6. Market By Sponsor
- 6.1. Pharmaceutical & Biopharmaceutical Companies
- 6.2. Medical Device Companies
- 6.3. Other Sponsors
- 7. Market By Service
- 7.1. Clinical Trial Site Management
- 7.2. Administrative Staff
- 7.3. Patient Recruitment Management
- 7.3.1. Patient Recruitment & Registry Services
- 7.3.2. Patient Retention
- 7.3.3. Other Patient Recruitment Management
- 7.4. Irb
- 7.5. Data Management
- 7.6. Other Services
- 8. Geographical Analysis
- 8.1. Europe
- 8.1.1. Market Size & Estimates
- 8.1.2. Key Growth Enablers
- 8.1.3. Key Challenges
- 8.1.4. Key Players
- 8.1.5. Country Analysis
- 8.1.5.1. United Kingdom
- 8.1.5.2. Germany
- 8.1.5.3. France
- 8.1.5.4. Spain
- 8.1.5.5. Italy
- 8.1.5.6. Sweden
- 8.1.5.7. Denmark
- 8.1.5.8. Hungary
- 8.1.5.9. Rest Of Europe
- 9. Competitive Landscape
- 9.1. Key Strategic Developments
- 9.1.1. Mergers & Acquisitions
- 9.1.2. Product Launches & Developments
- 9.1.3. Partnerships & Agreements
- 9.1.4. Business Expansions & Divestitures
- 9.2. Company Profiles
- 9.2.1. Advanced Clinical
- 9.2.2. Alcura
- 9.2.3. Charles River Laboratories Inc
- 9.2.4. Clinipace
- 9.2.5. Cti Clinical Trial And Consulting Services Inc
- 9.2.6. Icon Plc
- 9.2.7. Iqvia
- 9.2.8. Kcr
- 9.2.9. Labcorp Drug Development
- 9.2.10. Medpace
- 9.2.11. Parexel
- 9.2.12. Psi Cro
- 9.2.13. Syneos Health
- 9.2.14. Worldwide Clinical Trials
- 9.2.15. Wuxi Apptec
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook